JPH06265544A - Medicine and method for diagnosing hair damage - Google Patents
Medicine and method for diagnosing hair damageInfo
- Publication number
- JPH06265544A JPH06265544A JP34084093A JP34084093A JPH06265544A JP H06265544 A JPH06265544 A JP H06265544A JP 34084093 A JP34084093 A JP 34084093A JP 34084093 A JP34084093 A JP 34084093A JP H06265544 A JPH06265544 A JP H06265544A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- antibody
- protein
- damage
- diagnostic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Cosmetics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、毛髪損傷度診断薬及び
毛髪損傷度の診断方法に係り、更に詳しくは、ヒト毛髪
蛋白質に対して免疫活性を有する抗体に不溶化担体を固
定化させた修飾抗体からなる毛髪損傷度診断薬及び該診
断薬を用いた毛髪損傷度の診断方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hair damage diagnostic agent and a method for diagnosing hair damage, and more specifically, a modification in which an insolubilized carrier is immobilized on an antibody having an immunological activity against human hair protein. The present invention relates to a hair damage degree diagnostic agent comprising an antibody and a method for diagnosing a hair damage degree using the diagnostic agent.
【0002】[0002]
【従来の技術】毛髪は、外部環境・物理的要因・化学的
要因等によって、絶えず損傷の危険にさらされている。
しかしながら、毛髪は既に死んだ細胞の集合体であるた
め、一度損傷が生じてしまうと、その修復は不可能とな
る。従って、毛髪の損傷度を正しく評価し、なるべくそ
の損傷の早期にそれらの損傷を最小限に食い止める何ら
かの対策(ヘアートリートメント等)を施すことが求め
られている。又、パーマネントウェーブ、ヘアカラリン
グ、トリートメント等で適切な処理を行なうには、正確
な毛髪診断をしてからそれらの処理を行なうことが重要
な点となっている。2. Description of the Related Art Hair is constantly exposed to damage due to external environment, physical factors, chemical factors, and the like.
However, because hair is an assembly of already dead cells, once damaged, it cannot be repaired. Therefore, it is required to correctly evaluate the degree of damage to hair and take some measures (hair treatment etc.) to minimize the damage as early as possible. Further, in order to perform appropriate treatments such as permanent wave, hair coloring and treatment, it is important to perform accurate hair diagnosis and then perform those treatments.
【0003】従来の毛髪の損傷度の測定は、次のような
方法で行なわれている。まず、手指で触れたり、櫛です
いたときの感覚で、「髪がパサツク」「光沢がない」
「枝毛が多い」「髪に腰がない」「櫛通りが悪い」等を
感覚的に評価する方法がある。The conventional measurement of the degree of hair damage is carried out by the following method. First of all, "hair is dry" and "matte" as if touched with fingers or combed.
There is a method for sensuously evaluating "a lot of split ends", "the hair is not stiff", "combing is poor", and the like.
【0004】その他、種々の機器を用いた方法として、
〈顕微鏡にて観察する〉〈摩擦抵抗を測定する〉〈引っ
張り強度を測定する〉〈膨潤率を測定する〉〈アルカリ
溶解度を測定する〉〈アミノ酸の組成変化を測定する〉
等の方法が挙げられる。具体的には、光学顕微鏡や電子
顕微鏡にて毛髪表面の状態を観察したり、毛髪表面の損
傷に伴う摩擦抵抗の増大を測定したり、毛髪の伸張度を
測定したり、毛髪の水分吸収量を毛髪の重量増加で調べ
膨張率を求めたり、アルカリ処理に伴う毛髪重量変化を
求めたり、毛髪に多いシスチン量を測定しその減少率を
求めたりするものである。それらの測定には、光学顕微
鏡、電子顕微鏡、マイクロスコープ、ヘアテスター(テ
ンションメーター)、ペーハーメーター、ペーハー試験
紙、スンプ法セット、摩擦抵抗測定器、ヘアーゲージ等
が使われる。In addition, as a method using various devices,
<Observation with a microscope><measuring frictional resistance><measuring tensile strength><measuring swelling ratio><measuring alkali solubility><measuring compositional changes of amino acids>
And the like. Specifically, the condition of the hair surface can be observed with an optical microscope or an electron microscope, the increase in frictional resistance due to damage to the hair surface can be measured, the elongation of the hair can be measured, and the water absorption of hair. Is obtained by increasing the weight of the hair to obtain the expansion coefficient, the change in the hair weight due to the alkali treatment, and the amount of cystine in the hair is measured to obtain the decrease rate. For these measurements, an optical microscope, an electron microscope, a microscope, a hair tester (tension meter), a pH meter, a pH test paper, a sump method set, a friction resistance measuring device, a hair gauge, etc. are used.
【0005】上記のような試験を行なって総合的に毛髪
の損傷度を判定することが望ましいが、実際には、手で
触った感覚やシャンプーすることによる重量感等の感覚
によって判断するケースが多い。それは、上記に挙げた
測定装置は一般の人は通常持っていないものであるし、
一般美容室等においても全てを揃えられるものでもない
からである。さらに、それらの測定方法も簡単とはいえ
ず、又沢山の毛髪をいっぺんに短時間に測定できるもの
でもない。従って、毛髪の損傷度の判断は感覚的なもの
に頼っていることや個人がいつでも簡単に正確に判定で
きない状況にある。Although it is desirable to comprehensively determine the degree of hair damage by performing the above-mentioned test, in actual cases, the degree of hair damage may be determined by the sense of touch with the hand or the sense of weight due to shampooing. Many. It is because the general people do not have the above-mentioned measuring device,
This is because not all of them can be prepared in general beauty salons. Further, the measuring method thereof cannot be said to be simple, nor is it possible to measure many hairs at once in a short time. Therefore, the judgment of the degree of hair damage depends on sensory things, and individuals cannot always judge easily and accurately.
【0006】ところで毛髪は、外側をキューティクル
(毛表皮)でおおわれ、内部は毛髪繊維であるコルテッ
クス、そして中心のメジュラ(毛髄質)から構成されて
いる。毛髪は種々の要因によって絶えず損傷を受けてお
り、キューティクルの剥離又は内部ケラチン蛋白質の変
性や分解等が起こっている。そのため、シャンプー等で
洗髪するとケラチン蛋白質等を結びつけている間充物質
等の流出が起こり、その溶出量が多ければ多いほど、そ
の毛髪の損傷が激しいということができる。[0006] By the way, the hair is covered with a cuticle (hair epidermis) on the outside, a cortex which is a hair fiber, and a central medulla (hair medulla) on the inside. Hair is constantly damaged by various factors, and exfoliation of cuticles or degeneration or decomposition of internal keratin protein occurs. Therefore, it can be said that washing the hair with shampoo or the like causes outflow of the intercalation substance or the like that binds the keratin protein and the like, and the greater the elution amount, the more severe the hair is damaged.
【0007】[0007]
【発明が解決しようとする課題】本発明者らは、ヒト毛
髪蛋白質に対して免疫活性を有する抗体によって、上記
溶出物質を定量、及び毛髪の損傷部分を検出できること
を見出し、本発明を完成したものであって、その目的と
するところは、毛髪の損傷度を簡単に、迅速に、正確
に、且つ感度良く判定する方法及びその診断薬を提供す
るにある。The present inventors have completed the present invention by discovering that the above-mentioned eluted substances can be quantified and the damaged portion of hair can be detected by an antibody having an immunological activity against human hair protein. An object of the present invention is to provide a method for easily, quickly, accurately and sensitively determining the degree of hair damage and a diagnostic agent therefor.
【0008】[0008]
【課題を解決するための手段】上述の目的は、ヒト毛髪
蛋白質に対して免疫活性を有する抗体に不溶性担体を固
定化させた修飾抗体からなる毛髪損傷度診断薬、及び該
毛髪損傷度診断薬と毛髪、又は毛髪由来蛋白質との抗原
抗体反応を惹起せしめることを特徴とする毛髪損傷度の
診断方法によって達成される。Means for Solving the Problems The above-mentioned object is to provide a hair damage diagnostic agent comprising a modified antibody in which an insoluble carrier is immobilized on an antibody having immunological activity against human hair protein, and the hair damage diagnostic agent. It is achieved by a method for diagnosing the degree of hair damage, which comprises inducing an antigen-antibody reaction between the hair and the hair or a protein derived from the hair.
【0009】以下、本発明について詳細に説明する。The present invention will be described in detail below.
【0010】本発明に用いられるヒト毛髪蛋白質に対し
て免疫活性を有する抗体としては、毛髪を構成している
各種の成分に対する抗体が挙げられる。このような抗体
は、例えば毛髪ケラチン蛋白質あるいは、毛髪キューテ
ィクル蛋白質あるいは、細胞間充物質あるいは、毛髪マ
トリックス蛋白質あるいは、それらの断片等を抗原とし
て動物を免疫することにより得られる。更に、動物の
爪、体毛、羽毛等、又はそれらからの抽出物や断片等を
免疫することによっても得られるが、種差等を考慮すれ
ば、人間の毛髪、体毛が好ましく、特に毛髪を構成して
いる各種の成分が最も好ましい。Examples of the antibody having an immunological activity against the human hair protein used in the present invention include antibodies against various components constituting hair. Such an antibody can be obtained, for example, by immunizing an animal with a hair keratin protein, a hair cuticle protein, an intercellular substance, a hair matrix protein, or a fragment thereof as an antigen. Further, it can be obtained by immunizing animal nails, body hair, feathers, etc., or extracts or fragments thereof, etc., but considering the difference in species, human hair, body hair is preferable, and particularly hair is constituted. The various ingredients mentioned are most preferred.
【0011】免疫に用いられる動物としては、牛、馬、
羊、山羊、兎、ニワトリ等から適当な家畜を選ぶことが
できる。Animals used for immunization include cattle, horses,
Appropriate livestock can be selected from sheep, goats, rabbits, chickens and the like.
【0012】抗体は、これらの動物の常乳又は初乳、血
清、あるいは卵黄等より得ることができるが、牛の常乳
又は初乳あるいは卵黄より得られる抗体が、大量に取得
できるため好ましい。これらの抗体原料からの抗体の精
製は公知の方法に従えばよく、例えば適当な方法により
脂質を除いたのち、硫安分画法あるいはアルコール沈澱
法あるいは膜分離法などにより精製し、粗精製抗体を得
ることができる。必要ならばイオン交換クロマトグラフ
ィーやゲル濾過クロマトグラフィー等でさらに精製を行
ない精製抗体を得ることができる。更に必要ならば免疫
に用いた抗原をリガンドとするアフィニティークロマト
グラフィーを行なうことにより、高純度精製抗体を得る
ことができる。The antibody can be obtained from the normal milk or colostrum of these animals, serum, egg yolk, etc., but the antibody obtained from bovine normal milk or colostrum or egg yolk is preferable because a large amount can be obtained. Purification of antibodies from these antibody raw materials may be carried out by a known method. For example, after removing lipids by a suitable method, purification is carried out by ammonium sulfate fractionation method, alcohol precipitation method, membrane separation method, etc. Obtainable. If necessary, further purification can be performed by ion exchange chromatography, gel filtration chromatography or the like to obtain a purified antibody. Further, if necessary, high-purity purified antibody can be obtained by performing affinity chromatography using the antigen used for immunization as a ligand.
【0013】又、目的とする抗体を産生する抗体産生細
胞とミエローマ細胞の融合細胞からモノクローン抗体と
して抗体を得ることもできる。Further, an antibody can be obtained as a monoclonal antibody from a fused cell of an antibody-producing cell producing the desired antibody and a myeloma cell.
【0014】以上のようにして得られた抗体は、パパイ
ンあるいはペプシン等の酵素で処理し、免疫グロブリン
のFc部分を除去した抗体断片としてもよい。The antibody thus obtained may be an antibody fragment obtained by treating with an enzyme such as papain or pepsin to remove the Fc portion of immunoglobulin.
【0015】また、免疫した動物の脾臓細胞あるいはリ
ンパ球からクローニングされた免疫グロブリン遺伝子断
片を導入した微生物あるいは培養細胞の産物であっても
よい。Further, it may be a product of a microorganism or a cultured cell into which an immunoglobulin gene fragment cloned from spleen cells or lymphocytes of an immunized animal has been introduced.
【0016】本発明で使用される不溶性担体としては、
高分子粒子等が使用される。この高分子粒子は、水系に
て不溶性であればいずれの材料でも使用可能である。例
えば、合成高分子ポリマー、金属粒子、顔料、不溶性蛋
白質等が挙げられるが、分子設計が可能であり種々の条
件に対応できる点、色素や顔料の保持が容易である点、
及び大きさを均一にできるため診断薬としての定量性が
高いという点で、合成高分子ポリマーが好ましく、特に
ポリスチレン及び官能基を有するポリスチレンが好まし
い。The insoluble carrier used in the present invention includes
Polymer particles or the like are used. As the polymer particles, any material can be used as long as it is insoluble in an aqueous system. For example, synthetic high molecular polymers, metal particles, pigments, insoluble proteins and the like can be mentioned, but the point that they can be molecularly designed and can meet various conditions, and that dyes and pigments can be easily retained,
In addition, synthetic high molecular polymers are preferable, and polystyrene and polystyrene having a functional group are particularly preferable, because the size is uniform and the quantitativeness as a diagnostic agent is high.
【0017】合成高分子ポリマーとしては、以下のよう
なものが挙げられる。ポリスチレン、ポリ(α−メチル
スチレン)、ポリビニルトルエン、ポリクロルメチルス
チレン、ポリクロルスチレン、ポリ塩化ビニル、ポリ臭
化ビニル、ポリアクリロニトリル、ポリメタクリロニト
リル、ポリアクリル酸エチル、ポリアクリル酸オクチ
ル、ポリアクリル酸ヒドロキシプロピル、ポリアクリル
酸ブチル、ポリアクリル酸メトキシエチル、ポリアクリ
ル酸ヒドロキシエチル、ポリアクリル酸ラウリル、ポリ
アクリル酸アンモニウム、ポリメタクリル酸メチル、ポ
リメタクリル酸エチル、ポリメタクリル酸プロピル、ポ
リメタクリル酸ブチルアミノエチル、ポリヒドロキシメ
タクリル酸、ポリ酢酸ビニル、ポリアクリル酸、ポリメ
タクリル酸、ポリマレイン酸、ポリスチレンスルホン
酸、ポリ(2−アクリルアミド−2−メチルプロパンス
ルホン酸)、ポリアクリルアミド、ポリメタクリルアミ
ド、ポリ{N−(2−ヒドロキシプロピル)メタクリル
アミド}、ポリ(2−ヒドロキシエチルメタクリレー
ト)、ポリ(グリセロールモノメタクリレート)、ポリ
(2−オキシエチルアクリレート)、ポリ(2−オキシ
エチルメタクリレート)、ポリエチレングリコールメタ
クリレート、ポリエチレン、ポリプロピレン、ポリブテ
ン、ポリイソブテンおよびこれらの共重合体、ポリウレ
タン、及びポリウレタンとシリコン等との共重合体、ナ
イロンビーズ等である。Examples of the synthetic high molecular polymer include the following. Polystyrene, poly (α-methylstyrene), polyvinyltoluene, polychloromethylstyrene, polychlorostyrene, polyvinyl chloride, polyvinyl bromide, polyacrylonitrile, polymethacrylonitrile, ethyl polyacrylate, polyoctyl acrylate, poly Hydroxypropyl acrylate, butyl polyacrylate, methoxyethyl polyacrylate, hydroxyethyl polyacrylate, lauryl polyacrylate, ammonium polyacrylate, polymethylmethacrylate, polyethylmethacrylate, polypropylmethacrylate, polymethacrylic acid Butylaminoethyl, polyhydroxymethacrylic acid, polyvinyl acetate, polyacrylic acid, polymethacrylic acid, polymaleic acid, polystyrenesulfonic acid, poly (2-acrylamido-2-methyl) Lopansulfonic acid), polyacrylamide, polymethacrylamide, poly {N- (2-hydroxypropyl) methacrylamide}, poly (2-hydroxyethyl methacrylate), poly (glycerol monomethacrylate), poly (2-oxyethyl acrylate), Examples thereof include poly (2-oxyethyl methacrylate), polyethylene glycol methacrylate, polyethylene, polypropylene, polybutene, polyisobutene and copolymers thereof, polyurethane, copolymers of polyurethane and silicone, nylon beads and the like.
【0018】金属粒子としては、酸化チタンや磁性体粒
子等が挙げられる。Examples of the metal particles include titanium oxide and magnetic particles.
【0019】顔料としては、二酸化チタン、亜鉛華、酸
化クロム、カーボンブラック等の無機顔料及びファスト
イエロー、レーキレッドR4、ブリリアントファストス
カーレット、フタロシアニンブルー等の有機顔料等が挙
げられる。Examples of the pigment include inorganic pigments such as titanium dioxide, zinc oxide, chromium oxide and carbon black, and organic pigments such as fast yellow, lake red R4, brilliant fast scarlet and phthalocyanine blue.
【0020】不溶性蛋白質としては、中性で不溶性のも
のや、水溶性の蛋白質を架橋して不溶化・高分子化した
ものを使用すればよい。具体的には、フィブロイン、ゼ
ラチン、コラーゲン等が挙げられる。As the insoluble protein, a neutral insoluble protein or a water-soluble protein crosslinked to be insolubilized / polymerized may be used. Specific examples include fibroin, gelatin, collagen and the like.
【0021】これらの不溶性担体の形態については特に
限定されるものではなく、球形や板状であっても使用で
きるが、粒子サイズの揃った球形のものが好ましい。
又、大きさについては特に限定されないが、好ましくは
0.001〜100μmの大きさが良い。The form of these insoluble carriers is not particularly limited and may be spherical or plate-like, but spherical ones having a uniform particle size are preferred.
The size is not particularly limited, but preferably 0.001 to 100 μm.
【0022】不溶性担体に対する抗体の量は、一概に規
定されないが、抗体量が多い程、診断薬としての感度が
上がるため、飽和するまで抗体を固定化することが好ま
しい。The amount of antibody to the insoluble carrier is not generally specified, but the higher the amount of antibody, the higher the sensitivity as a diagnostic agent. Therefore, it is preferable to immobilize the antibody until it is saturated.
【0023】不溶性担体と上記抗体は物理的吸着または
化学的結合により固定化される。化学的結合に用いられ
る上記抗体の官能基としてはアミノ基、カルボキシル
基、チオール基、糖鎖部分などが考えられ、色素と担体
の結合の場合と同様にして結合させることができる。例
えば糖鎖部分を結合に用いる場合は糖鎖部分をメタ過ヨ
ウ素酸等で酸化してアルデヒド基を生成させ、担体のア
ミノ基との間でシッフ塩基形成により結合させることが
できる。チオール基を用いる場合はSPDP試薬等を用
いて結合させることができる。The insoluble carrier and the above antibody are immobilized by physical adsorption or chemical bonding. An amino group, a carboxyl group, a thiol group, a sugar chain portion and the like can be considered as the functional group of the above-mentioned antibody used for chemical bonding, and they can be bonded in the same manner as in the case of bonding the dye and the carrier. For example, when the sugar chain portion is used for binding, the sugar chain portion can be oxidized with metaperiodic acid or the like to generate an aldehyde group, and can be bound with the amino group of the carrier by Schiff base formation. When a thiol group is used, it can be bound using an SPDP reagent or the like.
【0024】本発明における不溶性担体に更に色素、顔
料等を保持させて着色すると、色によって判定が容易と
なるので好ましい。It is preferable that the insoluble carrier according to the present invention is further colored by holding a dye, a pigment or the like, because the color makes the determination easier.
【0025】着色に用いられる色素、顔料としては、タ
ール系色素を始めとする各種の合成色素、反応性色素、
蛍光色素、合成メラニン色素、動物、植物、微生物由来
の天然色素、有機または無機の顔料等を挙げることがで
きる。The dyes and pigments used for coloring include various synthetic dyes such as tar dyes, reactive dyes,
Examples thereof include fluorescent dyes, synthetic melanin dyes, natural dyes derived from animals, plants and microorganisms, organic or inorganic pigments and the like.
【0026】不溶性担体に色素、顔料等を保持させる方
法としては、物理的な方法と化学的な方法が考えられ
る。物理的な方法としては、色素、顔料を不溶性担体に
吸着させる吸着法、不溶性担体作製時に色素、顔料を添
加する内添法、不溶性担体内に色素、顔料を包み込む内
包法、不溶性担体内で色素前駆体を重合させる重合法等
がある。As a method for holding the dye, pigment and the like on the insoluble carrier, a physical method and a chemical method can be considered. As a physical method, a dye, an adsorption method of adsorbing a pigment to an insoluble carrier, a dye at the time of making an insoluble carrier, an internal addition method of adding a pigment, a dye in an insoluble carrier, an encapsulation method of wrapping a pigment, a dye in an insoluble carrier. There is a polymerization method in which a precursor is polymerized.
【0027】不溶性担体が官能基を有する場合、化学的
な方法により結合することができる。官能基としてはア
ミノ基、カルボキシル基、アルデヒド基、水酸基、チオ
ール基等が利用される。When the insoluble carrier has a functional group, it can be bound by a chemical method. As the functional group, an amino group, a carboxyl group, an aldehyde group, a hydroxyl group, a thiol group or the like is used.
【0028】色素、顔料等の添加量は、特に限定される
ものではないが、ラテックス等の表面に吸着させる場合
は、ラテックスを100として0.1〜10重量%の範
囲が好ましく、目視にて判定できる量であれば十分であ
る。例えば有機顔料であるレーキレッドR4を用いる場
合は、1重量%で十分な発色が得られる。又、合成高分
子ポリマーに内添する場合は、合成高分子ポリマーを1
00として0.1〜50重量%の範囲が好ましく、目視
にて判定できる量であれば十分である。例えば有機顔料
であるフタロシアニンブルーを用いる場合は、15重量
%で十分な発色が得られる。The amount of the dye, pigment or the like added is not particularly limited, but when adsorbed on the surface of latex or the like, the range of 0.1 to 10% by weight is preferable with latex as 100, and it is visually observed. The amount that can be determined is sufficient. For example, when Lake Red R4, which is an organic pigment, is used, sufficient coloring can be obtained with 1% by weight. When internally adding to a synthetic high molecular polymer, 1
The range of 0.1 to 50% by weight is preferable as 00, and it is sufficient if the amount can be visually determined. For example, when phthalocyanine blue, which is an organic pigment, is used, sufficient coloring can be obtained at 15% by weight.
【0029】以上のようにして得られた不溶性担体で修
飾したヒト毛髪蛋白質に対して免疫活性を有する抗体
は、種々の剤形に調製することができ、例えば水溶液等
適当な溶媒を用いた溶液として、又は分散液として使用
することができる。The antibody having immunological activity against the human hair protein modified with the insoluble carrier obtained as described above can be prepared in various dosage forms, for example, a solution using an appropriate solvent such as an aqueous solution. Or as a dispersion.
【0030】本発明の毛髪損傷度の診断方法は、例えば
次の様にして実施することができる。The method for diagnosing the degree of hair damage of the present invention can be carried out, for example, as follows.
【0031】ヒト毛髪を本発明の毛髪損傷度診断薬溶液
(又は分散液)に浸漬し、抗体抗原反応によって生ず
る、診断薬の毛髪表面への付着の度合いを測定する。そ
の度合いによって毛髪の損傷度を判定する。Human hair is immersed in the solution (or dispersion) of the diagnostic agent for the degree of hair damage of the present invention, and the degree of adhesion of the diagnostic agent to the hair surface caused by the antibody-antigen reaction is measured. The degree of hair damage is determined based on the degree.
【0032】又、毛髪を生理リン酸緩衝液(以下PBS
と略記する。)等に浸漬して抽出した蛋白質(これらを
毛髪由来蛋白質と言う。)の溶液と、本発明の毛髪損傷
度診断薬を混合し、抗体抗原反応によって生ずる凝集の
度合いを測定し、その度合いによって毛髪の損傷度を判
定することもできる。In addition, the hair is treated with physiological phosphate buffer (hereinafter referred to as PBS).
Is abbreviated. ) Etc. and extracted with a solution of proteins (these are called hair-derived proteins) and the hair damage diagnostic agent of the present invention are mixed, and the degree of aggregation caused by the antibody-antigen reaction is measured. It is also possible to determine the degree of hair damage.
【0033】[0033]
【実施例】以下に実施例をあげて、本発明を更に詳細に
説明するが、本発明はこれらに限定されるものではな
い。The present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto.
【0034】実施例1 (抗原の調製)男性の正常毛髪5gと女性の正常毛髪5
gとを混合し、2%ポリオキシエチレンラウリル硫酸ナ
トリウム(3E.O.)水溶液にて洗浄後、8M尿素、
0.2M2−メルカプトエタノール含有0.2Mトリス
塩酸緩衝液(pH9.2)2.5lに加え、50℃窒素
バブリング下1時間撹拌し、これをテフロンホモジナイ
ザーを用いてすりつぶした。更にこの抽出操作を繰り返
し、10,000×gで30分間遠心して不溶物を除
き、毛髪蛋白質を抽出し、抗原とした。Example 1 (Preparation of antigen) 5 g of normal male hair and 5 normal female hair
g, mixed with 2% sodium polyoxyethylene lauryl sulfate (3EO) aqueous solution, and then washed with 8M urea,
It was added to 2.5 L of 0.2 M tris-hydrochloric acid buffer solution (pH 9.2) containing 0.2 M 2-mercaptoethanol, stirred for 1 hour under nitrogen bubbling at 50 ° C., and mashed using a Teflon homogenizer. Further, this extraction operation was repeated, centrifugation was performed at 10,000 × g for 30 minutes to remove insoluble matter, and hair protein was extracted and used as an antigen.
【0035】(兎の免疫化)実施例1の抗原溶液の蛋白
質濃度をPBSにて2mg/mlに調整し、その溶液と
フロインドの完全アジュバンドを1:1の容量比で混合
して油中水系型のエマルジョンとし、3匹の兎の背中数
箇所に1匹あたり2ml皮下投与し2週間後、4週間後
更に同量を皮下投与した。7週間目に更に同量の抗原溶
液を耳静脈より静かにゆっくり30分間かけて投与し免
疫化した。(Immunization of Rabbit) The protein concentration of the antigen solution of Example 1 was adjusted to 2 mg / ml with PBS, and the solution was mixed with Freund's complete adjuvant at a volume ratio of 1: 1 to prepare oil. An aqueous emulsion was prepared by subcutaneously administering 2 ml per animal to several sites on the backs of 3 rabbits, and after 2 weeks and 4 weeks, the same amount was further administered subcutaneously. At the 7th week, the same amount of the antigen solution was gently administered from the ear vein slowly over 30 minutes for immunization.
【0036】(抗血清の採取)最終投与1週間経過後
(8週目)試験動物から採血し、遠心分離後、血清を採
取した。(Collection of antiserum) One week after the final administration (8th week), blood was collected from the test animal, centrifuged, and serum was collected.
【0037】(抗体の精製)次に、得られた抗血清60
mlにPBS60mlを加え、これに飽和硫酸アンモニ
ウム溶液(pH7.0)80mlを攪拌しながら徐々に
添加し、氷冷下1時間攪拌した。遠心分離(10,00
0×g)後、沈殿物を集め、PBS60mlにて溶解し
上記硫安塩析分画を繰り返した。得られた沈殿物を約1
20mlのPBSにて溶解し、PBSに対して透析し、
生じた沈殿物を遠心にて除き抗体を得た。(Purification of antibody) Next, the obtained antiserum 60
60 ml of PBS was added to ml, 80 ml of a saturated ammonium sulfate solution (pH 7.0) was gradually added to this with stirring, and the mixture was stirred for 1 hour under ice cooling. Centrifuge (10,000
After 0 × g), the precipitate was collected, dissolved in 60 ml of PBS, and the ammonium sulfate salting out fractionation was repeated. About 1 of the obtained precipitate
Dissolve in 20 ml PBS, dialyze against PBS,
The resulting precipitate was removed by centrifugation to obtain an antibody.
【0038】なお免疫化していない兎血清からも本手法
と同様に抗体を精製し、これを対照抗体とした。An antibody was purified from rabbit serum that was not immunized in the same manner as this method, and this was used as a control antibody.
【0039】(毛髪損傷度診断薬の調製)カルボキシ変
性ポリスチレンラテックス(0.19μm、白色)を固
体分濃度1%で蒸留水に分散したのち、塩酸でpH5.
0に調整した。1%濃度のラテックス分散溶液1容量部
に0.01M1−エチル−3−(3−ジメチルアミノプ
ロピル)カルボジイミド1容量部を加え攪拌し、室温下
2時間放置する。遠心分離後上清を除き、生理リン酸緩
衝液(以下PBSと略記する)1容量部を加えて再分散
操作を行なう。これにPBSにより1mg/mlに希釈
した上記抗体1容量部を加え攪拌し、室温下2時間放置
する。遠心分離後上清を除き、ウシ血清アルブミン(以
下BSAと略記する。)を0.1%の濃度で添加したP
BS1容量部を加えて再分散操作を行なった後、室温下
1時間放置する。さらに遠心分離後、BSAとポリオキ
シエチレンソルビタンモノラウレート(20E.O./
以下Tween20と略記する。)を0.1%の濃度で
添加したPBS1容量部を加えて再分散し、毛髪損傷度
診断薬を得た。(Preparation of Hair Damage Diagnostic Agent) Carboxy-modified polystyrene latex (0.19 μm, white) was dispersed in distilled water at a solid concentration of 1% and then adjusted to pH 5. with hydrochloric acid.
Adjusted to 0. 1 volume part of 0.01M 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide is added to 1 volume part of a latex dispersion solution having a concentration of 1%, and the mixture is stirred and left at room temperature for 2 hours. After centrifugation, the supernatant is removed, and 1 part by volume of physiological phosphate buffer solution (hereinafter abbreviated as PBS) is added to carry out a redispersion operation. To this, 1 part by volume of the above antibody diluted to 1 mg / ml with PBS is added, stirred, and left to stand at room temperature for 2 hours. After centrifugation, the supernatant was removed, and bovine serum albumin (hereinafter abbreviated as BSA) was added at a concentration of 0.1% to P.
After adding 1 part by volume of BS and carrying out a redispersion operation, the mixture is left at room temperature for 1 hour. After further centrifugation, BSA and polyoxyethylene sorbitan monolaurate (20 EO /
Hereinafter referred to as Tween 20. ) Was added at a concentration of 0.1% and redispersed by adding 1 part by volume of PBS to obtain a hair damage diagnostic agent.
【0040】本毛髪損傷度診断薬には、ラテックス重量
10mg当たり上記抗体が0.5mg結合していた。In the present hair damage diagnostic agent, 0.5 mg of the above antibody was bound per 10 mg of latex weight.
【0041】実施例2 不溶性担体として、青色色素(シラド化学社製、オイル
ブルーB)を吸着させたカルボキシ変性ポリスチレンラ
テックス(0.19μm)を用い、実施例1と同様にし
て毛髪損傷度診断薬を調製した。本毛髪損傷度診断薬に
は、ラテックス重量10mg当たり実施例1の抗体が
0.5mg結合していた。Example 2 As the insoluble carrier, a carboxy-modified polystyrene latex (0.19 μm) adsorbed with a blue dye (Oil Blue B, manufactured by Shirado Chemical Co., Ltd.) was used, and a hair damage diagnostic agent was prepared in the same manner as in Example 1. Was prepared. In the present hair damage diagnostic agent, 0.5 mg of the antibody of Example 1 was bound per 10 mg of latex.
【0042】比較例1 対照抗体を用い、実施例1と同様にして毛髪損傷度診断
薬を調製した。本毛髪損傷度診断薬には、ラテックス重
量10mg当たり対照抗体が0.5mg結合していた。Comparative Example 1 A control agent was used to prepare a hair damage diagnostic agent in the same manner as in Example 1. In this hair damage diagnostic agent, 0.5 mg of the control antibody was bound per 10 mg of the latex weight.
【0043】比較例2 実施例1で調製したヒト毛髪蛋白質に対して免疫活性を
有する抗体に、青色色素を直接結合させ、毛髪損傷度診
断薬を調製した。Comparative Example 2 A blue dye was directly bound to the antibody having an immunological activity against the human hair protein prepared in Example 1 to prepare a hair damage diagnostic agent.
【0044】試験例1 凝集試験 実施例1において作成した抗原である毛髪抽出蛋白質
を、PBSにより100μg/mlに希釈した。この抗
原溶液1容量部と実施例1〜2又は比較例1〜2の毛髪
損傷度診断薬各々1容量部を混合し、凝集反応を見た。
凝集試験の結果を表1に示す。凝集が全く認められない
場合は−、凝集の有無が判別し難い場合は±、明らかに
凝集が認められる場合、凝集の強い順に+++、++、
+と判定した。Test Example 1 Aggregation test The hair extract protein, which is the antigen prepared in Example 1, was diluted to 100 μg / ml with PBS. 1 part by volume of this antigen solution and 1 part by volume of each of the hair damage diagnostic agents of Examples 1 and 2 or Comparative Examples 1 and 2 were mixed, and an agglutination reaction was observed.
The results of the agglutination test are shown in Table 1. If no agglutination is observed at all-, if it is difficult to determine the presence or absence of agglutination ±, and if agglutination is clearly observed, the order of strong agglutination is ++, ++,
It was judged as +.
【0045】[0045]
【表1】 [Table 1]
【0046】表1から分かる通り、実施例1〜2の毛髪
損傷度診断薬は毛髪抽出蛋白質に対して特異的に反応
し、しかも不溶性担体によって、目視による凝集の判定
が可能であった。また、実施例2の毛髪損傷度診断薬
は、色素をも含有しているため、判定が容易であった。
一方、対照抗体を用いた比較例1の毛髪損傷度診断薬
は、毛髪抽出蛋白質に対して反応しなかった。また不溶
性担体を用いず、色素のみを結合させた比較例2の毛髪
損傷度診断薬は、発色が悪く、目視により凝集の有無を
判定することは、困難であった。As can be seen from Table 1, the hair damage diagnostic agents of Examples 1 and 2 specifically reacted with the hair extract protein, and the agglutination could be visually judged by the insoluble carrier. Further, the hair damage degree diagnostic agent of Example 2 also contained a pigment, so that the determination was easy.
On the other hand, the hair damage diagnostic agent of Comparative Example 1 using the control antibody did not react with the hair extract protein. Further, the hair damage degree diagnostic agent of Comparative Example 2 in which only the dye was bound without using an insoluble carrier had poor color development, and it was difficult to visually determine the presence or absence of aggregation.
【0047】試験例2 損傷診断 (1)毛髪蛋白質の抽出 0.1%Tween20含有PBS10mlに毛束
(0.1g)を浸漬し、室温下30分間回転させて攪拌
を行ない、正常毛髪抽出液を得た。次に市販のブリーチ
剤を用いて毛髪を数回繰り返して処理し、損傷毛髪とし
た。0.1%Tween20含有PBS10mlに損傷
毛髪の毛束(0.1g)を浸漬し、室温下30分間回転
させて攪拌を行ない、損傷毛髪抽出液を得た。Test Example 2 Diagnosis of Damage (1) Extraction of Hair Protein A hair bundle (0.1 g) was immersed in 10 ml of PBS containing 0.1% Tween 20, and the mixture was stirred at room temperature for 30 minutes to obtain a normal hair extract. Obtained. The hair was then treated several times with a commercially available bleaching agent to give damaged hair. A hair bundle (0.1 g) of damaged hair was immersed in 10 ml of PBS containing 0.1% Tween 20, and the mixture was stirred at room temperature for 30 minutes to obtain a damaged hair extract.
【0048】(2)凝集反応 正常毛髪および損傷毛髪の抽出液を、0.1%Twee
n20含有PBSで10倍および100倍に希釈した。
次いで実施例1の毛髪損傷度診断薬を倍数希釈法によ
り、0.1%Tween20含有PBSで希釈した。各
診断薬希釈液1容量部と毛髪抽出液の希釈液1容量部を
混合し、凝集反応を見た。凝集試験の結果を表2に示
す。なお、凝集が全く認められない場合は−、凝集の有
無が判別し難い場合は±、明らかに凝集が認められる場
合、凝集の強い順に+++、++、+と判定した。(2) Agglutination reaction The extracts of normal hair and damaged hair were treated with 0.1% Tween.
Diluted 10-fold and 100-fold with n20-containing PBS.
Next, the hair damage diagnostic agent of Example 1 was diluted with PBS containing 0.1% Tween 20 by the multiple dilution method. 1 part by volume of each diagnostic diluent was mixed with 1 part by volume of a hair extract, and the agglutination reaction was observed. The results of the agglutination test are shown in Table 2. In addition, when aggregation was not observed at all, − was determined if presence or absence of aggregation was difficult to determine, and when aggregation was clearly observed, it was determined as ++, ++, + in order of strong aggregation.
【0049】[0049]
【表2】 [Table 2]
【0050】表2から分かる通り、実施例1の毛髪損傷
度診断薬は、損傷毛髪の抽出液に対して強い凝集を示し
た。As can be seen from Table 2, the hair damage diagnostic agent of Example 1 showed strong aggregation with the extract of damaged hair.
【0051】また、比較例1の毛髪損傷度診断薬につい
て同様の試験を行なったが、凝集は全く認められなかっ
た。Further, the same test was carried out for the hair damage diagnostic agent of Comparative Example 1, but no aggregation was observed at all.
【0052】試験例3 損傷診断 市販のブリーチ剤を用いて毛髪を処理し、処理回数の異
なる損傷毛髪を調製した。0.1%Tween20含有
PBS10mlに各損傷毛髪の毛束(0.1g)を浸漬
し、室温下30分間回転させて攪拌を行ない、損傷毛髪
抽出液を得た。次いで試験例2と同様の操作を行ない、
実施例2の毛髪損傷度診断薬と損傷毛髪抽出液の凝集反
応を見た。凝集試験の結果を表3に示す。なお、凝集が
全く認められない場合は−、凝集の有無が判別し難い場
合は±、明らかに凝集が認められる場合、凝集の強い順
に+++、++、+と判定した。Test Example 3 Damage Diagnosis Hair was treated with a commercially available bleaching agent to prepare damaged hair treated differently. A hair bundle (0.1 g) of each damaged hair was dipped in 10 ml of PBS containing 0.1% Tween 20, and stirred at room temperature for 30 minutes to obtain a damaged hair extract. Then, the same operation as in Test Example 2 is performed,
The aggregation reaction of the hair damage degree diagnostic agent and the damaged hair extract of Example 2 was observed. The results of the aggregation test are shown in Table 3. In addition, when aggregation was not observed at all, − was determined if presence or absence of aggregation was difficult to determine, and when aggregation was clearly observed, it was determined as ++, ++, + in order of strong aggregation.
【0053】[0053]
【表3】 [Table 3]
【0054】表3より、ブリーチ剤による処理回数に対
応して凝集が強くなっており、本発明が毛髪損傷度診断
薬として有用であることが分かった。From Table 3, it was found that the coagulation became stronger according to the number of treatments with the bleaching agent, and the present invention is useful as a hair damage diagnostic agent.
【0055】試験例4 損傷診断 市販のパーマ剤を用いて試験例3と同様の操作を行な
い、毛髪損傷度診断薬と損傷毛髪抽出液の凝集反応を見
た。Test Example 4 Damage Diagnosis The same operation as in Test Example 3 was performed using a commercially available permanent agent, and the aggregation reaction of the hair damage diagnostic agent and the damaged hair extract was observed.
【0056】本試験例においても、パーマ剤による処理
回数に対応して凝集が強くなることが示された。Also in this test example, it was shown that the coagulation becomes stronger in accordance with the number of treatments with the permanent agent.
【0057】実施例3 青色色素(シラド化学社製、オイルブルーB)を吸着さ
せたポリスチレンラテックス(0.19μm)を固体分
濃度1%で蒸留水に分散した。該分散液1容量部にPB
Sにより1mg/mlに希釈した実施例1で調製したヒ
ト毛髪蛋白質に対して免疫活性を有する抗体1容量部を
加えて攪拌し、室温下2時間放置する。遠心分離後上清
を除き、0.1%BSA含有PBS1容量部を加えて再
分散操作を行なう。さらに遠心分離、再分散操作を繰り
返した後、0.1%BSA及び0.1%Tween20
を含有するPBS1容量部を加えて再分散し、毛髪損傷
度診断薬を得た。Example 3 A polystyrene latex (0.19 μm) having a blue dye (Oil Blue B, manufactured by Shirado Chemical Co., Ltd.) adsorbed thereon was dispersed in distilled water at a solid content concentration of 1%. PB in 1 volume part of the dispersion liquid
1 part by volume of an antibody having an immunological activity against the human hair protein prepared in Example 1 diluted with S to 1 mg / ml was added, and the mixture was stirred and allowed to stand at room temperature for 2 hours. After centrifugation, the supernatant is removed, and 1 part by volume of PBS containing 0.1% BSA is added to carry out a redispersion operation. After further repeating centrifugation and redispersion operations, 0.1% BSA and 0.1% Tween 20 were added.
1 part by volume of PBS containing was added and redispersed to obtain a hair damage degree diagnostic agent.
【0058】比較例3 対照抗体を用い、実施例3と同様にして毛髪損傷度診断
薬を調製した。Comparative Example 3 A control agent was used to prepare a hair damage diagnostic agent in the same manner as in Example 3.
【0059】実施例3の診断薬においても実施例1及び
2と同様に毛髪抽出蛋白質に対して特異的に反応するこ
とを示し、かつ損傷毛髪との凝集反応を示した。The diagnostic agent of Example 3 was also shown to react specifically with the hair extract protein as in Examples 1 and 2, and also showed an agglutination reaction with damaged hair.
【0060】また、比較例3の毛髪損傷度診断薬につい
て同様の試験を行なったが、凝集は全く認められなかっ
た。Further, the same test was conducted for the hair damage diagnostic agent of Comparative Example 3, but no aggregation was observed.
【0061】実施例4 不溶性担体として、蛍光色素で染色したポリスチレンラ
テックス、もしくは市販の生化学試験用として市販され
ている蛍光ラテックスを用い、実施例3と同様にして毛
髪損傷度診断薬を調製した。本毛髪損傷度診断薬には、
ラテックス重量10mg当たり実施例1の抗体が0.5
mg結合していた。Example 4 A hair damage diagnostic agent was prepared in the same manner as in Example 3, using polystyrene latex dyed with a fluorescent dye or a commercially available fluorescent latex for a biochemical test as the insoluble carrier. . This hair damage diagnostic agent
The antibody of Example 1 was 0.5 per 10 mg of latex.
mg bound.
【0062】比較例4 対照抗体を用い、実施例4と同様にして毛髪損傷度診断
薬を調製した。Comparative Example 4 A control agent was used to prepare a hair damage diagnostic agent in the same manner as in Example 4.
【0063】比較例5 実施例1の抗体に蛍光色素を直接結合させ、毛髪損傷度
診断薬を調製した。Comparative Example 5 A fluorescent dye was directly bound to the antibody of Example 1 to prepare a hair damage diagnostic agent.
【0064】試験例5 市販のパーマ剤を用いて毛髪を処理し、処理回数の異な
る損傷毛髪を調製した。実施例4または比較例4〜5の
診断薬1mlに損傷毛髪の毛束(0.1g)を浸漬し、
室温下10分間回転させる。次いで0.05%Twee
n20含有生理食塩水で洗浄後、乾燥させた。暗所にて
蛍光色素の励起波長を持つ光源(市販の紫外線ランプな
ど)を用いて励起波長の光線を照射した結果を表4に示
す。蛍光を認めない場合は−、凝集の有無が判別し難い
場合は±、蛍光が認められる場合、蛍光の強い順に+
+、+と判定した。Test Example 5 Hair was treated with a commercially available perm agent to prepare damaged hair treated differently. A bundle of damaged hair (0.1 g) is immersed in 1 ml of the diagnostic agent of Example 4 or Comparative Examples 4 to 5,
Rotate for 10 minutes at room temperature. Then 0.05% Twee
After washing with a physiological saline solution containing n20, it was dried. Table 4 shows the results obtained by irradiating a light beam having an excitation wavelength with a light source having an excitation wavelength of a fluorescent dye (such as a commercially available ultraviolet lamp) in a dark place. When fluorescence is not observed, −, when it is difficult to determine the presence or absence of aggregation ±, when fluorescence is observed, + in order of strong fluorescence
It was judged as + and +.
【0065】[0065]
【表4】 [Table 4]
【0066】表4より、実施例4の毛髪損傷度診断薬は
パーマ処理回数に対応して蛍光強度が増しており、本発
明が毛髪損傷度診断薬として有用であることが分かっ
た。一方、対照抗体を用いた比較例4の毛髪損傷度診断
薬は、蛍光を認めなかった。また蛍光色素のみを結合さ
せた比較例5の毛髪損傷度診断薬は、発色が悪く、目視
により蛍光の有無を判定することは、困難であった。From Table 4, it was found that the diagnostic agent for hair damage of Example 4 had an increased fluorescence intensity corresponding to the number of times of perm treatment, and the present invention is useful as a diagnostic agent for hair damage. On the other hand, the hair damage diagnostic agent of Comparative Example 4 using the control antibody did not show fluorescence. Further, the hair damage degree diagnostic agent of Comparative Example 5 to which only the fluorescent dye was bound had poor color development, and it was difficult to visually determine the presence or absence of fluorescence.
【0067】[0067]
【発明の効果】本発明の毛髪損傷度診断薬を用いれば、
毛髪の損傷度を正確・迅速かつ簡便に判定することがで
きる。EFFECT OF THE INVENTION With the hair damage diagnostic agent of the present invention,
The degree of hair damage can be determined accurately, quickly and easily.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 村上 梅司 神奈川県小田原市寿町5丁目3番28号 鐘 紡株式会社生化学研究所内 (72)発明者 平岡 淳一郎 神奈川県小田原市寿町5丁目3番28号 鐘 紡株式会社生化学研究所内 (72)発明者 杉本 憲一 神奈川県小田原市寿町5丁目3番28号 鐘 紡株式会社化粧品研究所内 (72)発明者 南野 博美 神奈川県小田原市寿町5丁目3番28号 鐘 紡株式会社化粧品研究所内 (72)発明者 薬丸 雅史 神奈川県小田原市寿町5丁目3番28号 鐘 紡株式会社化粧品研究所内 (72)発明者 松尾 透 神奈川県小田原市寿町5丁目3番28号 鐘 紡株式会社化粧品研究所内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Umeji Murakami 5-328, Kotobuki-cho, Odawara-shi, Kanagawa Inside Kanebo Co., Ltd. Biochemical Research Laboratory (72) Inventor Junichiro Hiraoka 5-chome, Kotobuki-cho, Odawara, Kanagawa No. 3-28 Kanebo Co., Ltd. Biochemistry Research Institute (72) Inventor Kenichi Sugimoto 5-3 28, Kotobukicho, Odawara-shi, Kanagawa Kankobo Co., Ltd. Cosmetic Research Institute (72) Inventor Hiromi Minamino Hisashi Odawara-shi, Kanagawa Prefecture 5-3-28 Machi Kanebo Co., Ltd. in the Cosmetic Research Laboratory (72) Inventor Masashi Yakumaru 5-3 28 Kotobukicho, Odawara-shi, Kanagawa Kanbo Spinning Co., Ltd. (72) Inventor Toru Matsuo Odawara, Kanagawa Prefecture 5-3-28, Kotobuki-cho, Kanebo Co., Ltd., Cosmetic Research Laboratory
Claims (2)
る抗体に不溶性担体を固定化させた修飾抗体からなる毛
髪損傷度診断薬。1. A diagnostic agent for a degree of hair damage, which comprises a modified antibody obtained by immobilizing an insoluble carrier on an antibody having an immunological activity against human hair protein.
髪又は毛髪由来蛋白質を混合し、修飾抗体と前記毛髪又
は毛髪由来蛋白質との抗体抗原反応を惹起せしめること
を特徴とする毛髪損傷度の診断方法。2. A hair damage characterized by mixing the diagnostic agent for a degree of hair damage according to claim 1 and a hair or a hair-derived protein to induce an antibody-antigen reaction between a modified antibody and the hair or the hair-derived protein. Degree diagnostic method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5340840A JP3065869B2 (en) | 1992-12-08 | 1993-12-08 | Hair damage degree diagnostic agent and hair damage degree diagnostic method |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35197292 | 1992-12-08 | ||
JP4-351972 | 1992-12-08 | ||
JP5340840A JP3065869B2 (en) | 1992-12-08 | 1993-12-08 | Hair damage degree diagnostic agent and hair damage degree diagnostic method |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06265544A true JPH06265544A (en) | 1994-09-22 |
JP3065869B2 JP3065869B2 (en) | 2000-07-17 |
Family
ID=26576810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5340840A Expired - Fee Related JP3065869B2 (en) | 1992-12-08 | 1993-12-08 | Hair damage degree diagnostic agent and hair damage degree diagnostic method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3065869B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001042783A1 (en) * | 1999-12-08 | 2001-06-14 | Henkel Kommandigtsellschaft Auf Aktien | Process for determining the degeneration level of keratinic fibers (hair) |
JP2002107362A (en) * | 2000-09-29 | 2002-04-10 | Seiren Co Ltd | Method for diagnosing damage to hair |
-
1993
- 1993-12-08 JP JP5340840A patent/JP3065869B2/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001042783A1 (en) * | 1999-12-08 | 2001-06-14 | Henkel Kommandigtsellschaft Auf Aktien | Process for determining the degeneration level of keratinic fibers (hair) |
US6672143B2 (en) | 1999-12-08 | 2004-01-06 | Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) | Process for determining the degeneration level of keratinic fibers |
JP2002107362A (en) * | 2000-09-29 | 2002-04-10 | Seiren Co Ltd | Method for diagnosing damage to hair |
JP4523137B2 (en) * | 2000-09-29 | 2010-08-11 | セーレン株式会社 | Hair damage diagnosis method |
Also Published As
Publication number | Publication date |
---|---|
JP3065869B2 (en) | 2000-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ceska et al. | Radioimmunosorbent assay of allergens | |
US5597386A (en) | Hair coloring composition comprising anti-hair antibodies immobilized on coloring materials, and hair coloring methods | |
Bartholome et al. | Where does cat allergen 1 come from? | |
NZ201583A (en) | Method for the detection of pregnancy | |
JPH0441413A (en) | Hair modifying agent | |
JPS6161062B2 (en) | ||
Sheffield et al. | Studies on plasma membranes: XVI. Tissue specific antigens in the liver cell surface | |
Wood et al. | Blocking-immunofluorescence studies on the specificity of pemphigus autoantibodies | |
Stulberg et al. | Species-related antigens of mammalian cell strains as determined by immunofluorescence. | |
JP3065869B2 (en) | Hair damage degree diagnostic agent and hair damage degree diagnostic method | |
JP2006317226A (en) | Detecting reagent and detecting method for raw material derived from heat-treated animal tissue | |
Radermecker et al. | Anti-P1 activity in pigeon breeders' serum. | |
Freeman et al. | Reaction of antinucleoside antibodies with human cells in vitro | |
JPS58756A (en) | Method of fixing antigen and antibody onto polysaccharide supporter and use to immunological medicine compounding of product obtained in this manner | |
MOORE et al. | The immunological integrity of matrix substance A and its possible detection and quantitation in urine | |
AU625344B2 (en) | Chlamydia half-sandwich immunoassay | |
FR2640143A1 (en) | POLYMERIZED ANTIBODIES, DIRECTED AGAINST IMMUNOGLOBULINS - THEIR USE IN DIAGNOSTIC TESTS | |
FR2644894A1 (en) | KIT AND ENZYMATIC DETERMINATION METHOD APPLICABLE TO ENTIRE CELLS | |
EP1700128A2 (en) | Method for serological diagnosis and determination of immunisation status, comprising various controls | |
Milgrom et al. | Double diffusion in gel tests with Paul-Bunnell antibodies of infectious mononucleosis sera | |
KR100261050B1 (en) | Swine Ozeski's Disease Antibody Testing Device Using Immunochromatography | |
Leffingwell et al. | Rabies antibodies in human serums titrated by the indirect FA method. | |
Cherry et al. | Diagnostic immunofluorescence | |
JPS5994068A (en) | Detection of l.'s cell membrane antibody in blood by rosette forming method | |
Björklund et al. | Tissue polypeptide antigen (TPA) in human cancer defense responses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |